The rise in the share price came after the company announced that it has received World Health Organisation (WHO) prequalification approval for Albendazole Active Pharmaceutical Ingredient (API).
Original Image Link
Source:www.business-standard.com
Original Image Link
Source:www.business-standard.com
Posted: 2024-08-19 09:25:00